UBS has reiterated its "Neutral" rating for Givaudan, with a price target of 4,520 francs, following an investor event focused on the company's fragrance business.
Analyst Charles Eden discussed the ongoing discussions surrounding the expected slowdown in growth in this segment, particularly the timing and extent of the decline and its potential impact on profitability.
The report, published on October 23, 2024, reflects UBS's cautious stance in light of changing market conditions. These developments are being closely monitored by investors as they could affect Givaudan's financial performance in the upcoming quarters.